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ABSTRAK 
 
Schwannoma saraf kranial ke VII (fasial) merupakan ketumbuhan yang perlahan tum-
besarannya dan jarang berlaku, yang terhasil dari sel Schwann pada neurilemma. Ka-
jian retrospektif ke atas 6 pesakit yang didiagnosa dengan Schwannoma saraf kranial 
fasial antara tahun 1998 dan 2008 telah dijalankan. Kajian menunjukkan 3 pesakit 
adalah perempuan dan selebihnya lelaki. Purata umur mereka adalah 42 tahun (dari 
19 hingga 66 tahun). Ketumbuhan tersebut berasal dari bahagian  kanal auditori inter-
nal (2 pesakit), intra-temporal (3 pesakit) dan intraparotid (1pesakit). Kesemua ketum-
buhan tersebut telah dibedah dengan jayanya dan kesinambungan saraf kranial fasial 
dapat dikekalkan dalam 2 pesakit. Kajian menunjukkan bahawa gejala Schwannoma 
saraf kranial fasial boleh menyerupai ketumbuhan jenis lain yang melibatkan bahagian 
saraf kranial fasial yang sama. Pakar bedah mesti sentiasa peka dengan kewujudan-
nya terutamanya bila pesakit datang dengan gejala kelemahan saraf fasial yang pro-
gresif. Pesakit pula sentiasa perlu diberitahu mengenai kemungkinan komplikasi saraf 
fasial lumpuh kerana diagnosa Schwannoma saraf kranial fasial hanya dapat dikenal-
pasti semasa waktu pembedahan. 
 
Kata kunci: Schwannoma saraf kranial fasial, tulang temporal, kelenjar parotid
 
ABSTRACT  
 
Facial nerve schwannoma is a rare slow growing benign tumour which arises from the 
Schwann cell of the neurilemma. A retrospective review of 6 patients who had been 
diagnosed with facial nerve schwannoma between 1998 and 2008 was conducted. 
There was equal distribution of male and female patients. The mean age was 42 years 
(range 19 to 66 years). The tumour originated in the internal auditory canal (2 pa-
tients), intra-temporal (3 patients) and intraparotid (1 patient) segments of the facial 
nerve.  All tumours were successfully removed and facial nerve continuity was pre-
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served in 2 cases. The presenting symptoms of facial nerve schwannoma are non 
specific and dependent on the site of tumour origin. It is a great mimicker of other le-
sions that can present at the same location. The surgeon should have a high index of 
suspicion when patients present with progressive facial nerve palsy. Patients should 
always be counselled regarding risk of facial paralysis because the diagnosis of facial 
nerve schwannoma is often confirmed intra-operatively. 
 
Key words:  facial nerve schwannoma, temporal bone, parotid gland 
 
 
INTRODUCTION 
 
Facial nerve schwannoma (FNS) is a 
rare slow growing benign tumour. 
Schwannomas arise from the Schwann 
cell of the neurilemma and can involve 
the cranial nerve, spinal nerve and sym-
pathetic nerve. In 60% of cases, 
schwannoma usually arises from the 
cranial nerves, commonly of the sensory 
type (Sarma et al. 2002). Of all the possi-
ble cranial nerves involved, vestibular 
schwannomas are the most common. In 
a reported series of 46 patients the 
commonest nonvestibular schwannomas 
are trigeminal (56.5%), followed by facial 
schwannomas (15.2%), glossopharyn-
geal nerve (15.2%), vagus and spinal 
accessory nerve (4.4% patients), hypog-
lossal schwannomas (6.5%) and oculo-
motor (2.2%). Involvement of other 
cranial nerves such as trochlear and ab-
ducens nerves are rare.  
Facial nerve schwannoma can involve 
any segment of the nerve where each 
has a unique presentation. It is the com-
monest tumour among primary facial 
nerve tumours. This case series review 
aims to provide data on the clinical pres-
entation of FNS and its management. 
 
MATERIALS AND METHODS 
 
A retrospective analysis of 6 consecutive 
cases of FNS managed between 1998 
and 2008 was conducted. All these pa-
tients had histological confirmation of 
schwannoma from their surgical speci-
mens. The location of the tumor was de-
termined by imaging pre-operatively and 
confirmed intra-operatively. Tumours 
arising within the tympanic and mastoid 
segment were grouped as intratemporal 
tumours. The facial nerve function was 
evaluated with the House-Brackmann 
facial nerve grading system.  The post-
operative evaluation for recurrence was 
performed either clinically or in patients 
with intracanalicular FNS, and evaluation 
was by magnetic resonance imaging. 
 
RESULTS 
 
Six patients (3 females, 3 males) with an 
average age of 42 years (age range 19 
to 66 years) were included in this study 
(Table 1). The mean follow up period 
was 2 years. The FNS originated in the 
internal auditory canal (IAC) (2 cases, 
33%), intratemporal (3 cases, 50%) and 
intraparotid (1 case, 16.6%) segments of 
the facial nerve. The commonest initial 
presenting symptom was reduced hear-
ing and tinnitus (5 out of 6 cases). Pro-
gressive facial nerve palsy occurred in 3 
patients during the course of the disease 
(2 with intratemporal FNS and 1 with IAC 
FNS). The patient with intraparotid FNS 
only presented with parotid swelling and 
did not have facial nerve (FN) palsy or 
hearing loss. In this current series we 
observed that tumours which involved 
the tympanic segment would initially 
present with tinnitus, ear blockage and 
conductive hearing loss followed by FN 
palsy. However, there was one patient 
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Table 1: Demographic data and clinical summary of patients with facial nerve schwannoma. 
 
Symptoms (months) 
Facial nerve grade 
HB 
No 
Age 
(yrs) 
Sex Facial 
nerve 
palsy 
Hearing 
loss 
Tinnitus Imbalance Others 
Facial nerve 
segment 
involvement 
Type of Operation 
Preop Postop 
1 66 M 8 10 10 nil nil 
Tympanic 
segment 
MRM with nerve 
preservation 
IV IV 
2 43 F 4 8 8 nil nil 
Tympanic 
segment 
MRM with nerve 
preservation 
III III 
3 48 F nil 6 3 nil nil 
Tympanic 
segment 
MRM with cable 
grafting 
I IV 
4 49 M nil 48 48 24 nil IAC, CPA 
Posterior cranial 
fossa approach 
I V 
5 28 M 12 3 6 nil dysacusia 
IAC, middle 
cranial fossa 
Middle cranial fossa 
approach 
V V 
6 19 F nil nil nil nil 
parotid 
swelling 
Intraparotid 
Parotidectomy with 
reanastomoses 
I III 
MRM - Modified radical mastoidectomy; HB - House-Brackmann grade; IAC - Internal acoustic canal; CPA - Cerebellopontine angle 
 
who developed progressive sensori-
neural hearing loss which could be 
explained by bony erosion of the basal 
turn of the cochlea by the tumour. 
The three patients with intratemporal 
FNS had successful tumour excision via 
transmastoid approach. Otoscopic ex-
amination revealed a mass medial to the 
tympanic membrane (Figure 1). Intra-
operative findings revealed FNS involv-
ing the tympanic segment in these three 
patients. The continuity of the facial 
nerve was preserved in 2 patients. The 
other patient had tumour excision in-
cluding part of the facial nerve which was 
then repaired by sural nerve cable graft-
ing. The facial nerve had to be resected 
as it was adherent to the tumour and 
could not be separated. 
The patient with intraparotid FNS had 
complete removal of the tumour following 
superficial parotidectomy. Pre-operative 
imaging showed features of a benign pa-
rotid tumour. Fine needle aspiration cy-
tology was inconclusive. Intra-operative 
findings revealed a partially cystic tumour 
arising from the facial nerve trunk. In this 
case the facial nerve was sacrificed and 
end-to-end facial nerve anastomoses 
were performed.  
Both patients with FNS involving the 
IAC presented with hearing loss and tin-
nitus. One of them is a cook who pre-
sented late with complaint of dysacusia 
despite having had facial nerve palsy for 
nine months. He also had profound sen-
sorineural hearing loss. Intra-operative 
findings showed a large tumour at the 
IAC involving the geniculate ganglion ex-
tending superiorly into the middle cranial 
fossa which corresponded to the pre-
operative imaging studies (Figures 2 and 
3). The tumour was removed via a mid-
dle cranial fossa approach. 
The other patient with IAC FNS pre-
sented with a 2 year history of hearing 
loss and tinnitus with recent onset of im-
balance. Imaging studies showed tumour 
arising from the IAC with extension into 
the cerebellopontine angle. A pre-opera-
tive diagnosis of vestibular schwannoma 
was made. Intra-operative findings re-
vealed the tumour originated from the 
facial nerve. The tumour was success-
fully excised via posterior fossa craniot-
omy approach. In both these patients, 
the FNs were sacrificed and could not be 
anastomosed due to a short proximal 
stump.  
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Figure 1: Otoscopic view of tympanic segment 
facial schwannoma which showed a mass behind 
an intact tympanic membrane (arrow). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Axial HRCT scan showing widening of the 
right internal acoustic meatus and labyrinthine 
segment of the fallopian canal (arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Axial contrast HRCT scan showing hyper-
dense mass occupying the right IAC extending into 
the middle cranial fossa and indenting the temporal 
lobe (arrows). 
 
Patients who had preservation of the 
facial nerve continuity had the same 
functional grading pre- and post-
operatively. Two patients who had re-
anastomoses or cable grafting had 
deterioration of the facial nerve function 
from normal to grade III and IV 
respectively. Another two patients with 
IAC FNS whose facial nerve could not be 
grafted had post-operative facial nerve 
grade V (Table 1). 
 
DISCUSSION 
 
Primary facial nerve tumor is rare with an 
incidence of 1:23,000 ear cases (Sham-
baugh et al. 1969). The commonest pri-
mary facial nerve tumor is schwannoma. 
Falcioni et al. (2003) had reported a series 
of 28 primary facial nerve tumour in which 
18 were schwannomas, 6 were 
hemangiomas, 2 were meningiomas and 
2 were neurofibromas. FNS may arise 
from any segment of the facial nerve from 
the cerebellopontine angle (CPA) to the 
peripheral branch in the parotid gland. 
Multiple-segment localization can also 
occur. Sherman et al. (2002) reported that 
the most common segment involved is the 
labyrinthine (43.5%), followed by tympanic 
(42.8%), vertical (36.7%), canalicular 
(24.3%), cerebellopontine angle (17.8%), 
peripheral (15%), chorda tympani (1.2%) 
and nerve to stapedius (0.9%) in his 
literature review of 428 cases.  
The presenting symptoms of FNS may 
mimic any tumour that can arise at the 
same origin. Patients usually present late 
due to the non-specific symptoms. Sus-
picion is raised pre-operatively when pa-
tients present with progressive or relaps-
ing facial nerve palsy. In reality, many pa-
tients present with hearing loss and tinni-
tus as observed in this study. Sherman et 
al. (2002) in his meta-analysis of cases of 
FNS had shown that facial weakness was 
present in 63.2% of patients, hearing loss 
in 50.6% and tinnitus in 20.6%. Other 
symptoms including otalgia, otorrhoea and 
loss of taste were seen in less than 10%. 
On the other hand, his personal case se-
ries showed hearing loss as the most 
common presenting symptom, similar to 
the current study. In addition, many FNS 
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cases are diagnosed intra-operatively and 
confirmed by histology of surgical speci-
mens. The presence of facial nerve palsy 
also gives no indication to the exact site of 
origin as observed in our series as well. A 
previous study suggested that facial nerve 
palsy is more prevalent in intratemporal 
tumours when compared to extratemporal 
tumours (Park et al. 2007). 
Extratemporal FNS is the most uncom-
mon site to be involved. Interestingly in 
this series there was one patient who pre-
sented with 3 years history of progressive 
painless parotid tumor without facial nerve 
palsy. The diagnosis was only suspected 
intra-operatively. A retrospective study of 
8 cases of intraparotid schwannoma by 
Caughey et al. (2004) showed that only 
37.5% of them presented with facial nerve 
palsy. Therefore, it is often difficult to diffe-
rentiate FNS from other common benign 
parotid tumours.  
It is also difficult to differentiate intraca-
nalicular FNS from vestibular schwan-
noma (VS) especially when the only pre-
senting symptoms are hearing loss and 
tinnitus. Park et al. (2007) in a series of 
11 cases of intranalicular schwannomas, 
had reported 2 (11%) cases of FNS. In 
both cases, the diagnoses were made 
intra-operatively. There is no gold stan-
dard objective pre-operative assessment 
which can confirm the diagnosis for bet-
ter counselling of the patient. Previous 
studies recommend that there is post-
erior displacement of the tumour in FNS 
relative to the IAC in magnetic resonance 
imaging (MRI) (T1 weighted images post 
gadolinium). However, when the FNS fills 
up the entire diameter of the IAC it can 
no longer be differentiated from VS 
(Caughey 2004, Jäger & Reiser 2001). 
On the other hand, the presenting 
symptom of facial nerve palsy more likely 
supports the diagnosis of FNS as shown 
in one of our cases because facial nerve 
palsy in VS is extremely rare 
(O’Donoghue 1989).  
The recommended radiological imaging 
in cases of suspected FNS is CT or MRI. 
The radiological findings of FNS are similar 
to schwannoma of other nerves. CT scan 
will show an enhancing soft tissue mass 
with lack of bony destruction due to its 
benign nature. Bone algorithm will 
demonstrate an expansile bony lesion with 
lytic changes or remodeling of bone. This 
imaging is most useful in showing the 
extension of intratemporal FNS (Figures 2 
and 3). 
On the other hand, MRI gives the best 
soft tissue quality and will show a mildly 
hypo or isointense lesion relative to the 
brain in T1-weighted images. On T2-
weighted images, the tumor is heteroge-
neously hyperintense which will further 
enhance with gadolinium (Ginsberg & 
DeMonte 1999). In cases of intracanali-
cular FNS, combined modality of CT and 
MRI is recommended to differentiate be-
tween FNS and VS (Martin et al. 1992). 
MRI findings of FNS may show presence 
of labyrinthine tail which represents tu-
mour extension into the labyrinthine canal 
(Ramina et al. 2008). High resolution CT 
findings of pressure erosion at the antero-
superior margin of the IAC and/or subtle 
bone erosion of the first segment of the 
fallopian canal are suggestive of FNS. 
However, these findings are irrelevant in 
large intracanalicular tumours (Caughey 
2004, Jäger & Reiser 2001). 
The mainstay treatment for FNS is sur-
gical excision. The aim of surgery in FNS 
is complete tumor excision with preser-
vation of the facial nerve and hearing 
function. The timing and method of sur-
gery depend on the presenting facial 
nerve function, location and size of the 
tumor and hearing status. As majority of 
the cases of FNS is diagnosed intra-ope-
ratively, the decision on preservation of 
facial nerve can be only determined on 
table. Therefore, pre-operative patient 
counselling regarding facial nerve function 
risk is of utmost importance in all cases. In  
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most symptomatic cases, surgical 
resection with sacrifice of the involved 
facial nerve segment is often necessary. 
Some authors advocate that a facial nerve 
palsy of House Brackmann grade III or 
worse should encourage sacrifice of the 
facial nerve followed by end to end 
anastomosis or grafting (Chung et al. 
2004).  
Patients with minimal facial or no facial 
dysfunction poses the greatest dilemma to 
the surgeon. This is because surgical 
treatment would inevitably lead to some 
degree of facial paralysis. However, some 
authors believe that patients with minimal 
facial dysfunction of shortest duration pre-
operatively will have better facial nerve 
function outcome after surgery (Yamaki et 
al. 1998). They argue that in these cases 
the shortest distance for anastomosis is 
still achievable.  When the tumour is large 
there is increased risk of compression of 
important structures such as the brains-
tem and the surgery becomes technically 
challenging. A longer segment of the 
nerve has to be resected, that end to end 
anastomosis is not possible and inability 
to graft the resected segment is due to 
short proximal nerve stump especially in 
intracranial FNS. Although surgical resec-
tion is the primary mode of treatment, 
other treatment options can be consi-
dered. Liu & Fagan (2001) had conserva-
tively managed 8 out of 10 patients with 
tumors confined to the intracanalicular 
and cerebellopontine angle. The patients 
had serial imaging for tumour monitoring. 
They showed that 80% of the patients 
maintained their facial nerve function for 
up to 10 years with no significant tumour 
growth on serial imaging. Stereotactic 
radiosurgery has been considered for 
management of FNS in a small number of 
patients. It is a viable option for those pa-
tients who are medically unfit for surgery 
(Sherman et al. 2002). A recent article 
had highlighted the role of stereotactic 
radiotherapy in FNS (Nishioka et al. 
2009). In four patients with FNS, they had 
shown that the tumour size decreased or 
unchanged after a median total dose of 59 
Gray. The facial nerve function of these 
patients also improved or remained the 
same post treatment with a mean follow 
up of 67.3 months. They concluded that 
stereotactic radiotherapy is as effective as 
stereotactic radiosurgery and may prove 
to be more efficacious in preserving neu-
rological function. However, a larger follow 
up study needs to be performed to prove 
this claim. 
Facial nerve function is inevitably at risk 
in surgical resection of FNS. However, as 
it is often an intra-operative diagnosis, 
surgical consent of facial nerve palsy 
should always be sought. Park et al. 
(2007) had shown in a series of intraca-
nalicular schwannomas, the possibility of 
facial nerve schwannoma was 11%. 
When the facial nerve integrity has to be 
sacrificed, end to end anastomosis or ca-
ble graft are the preferred choices for 
best prognosis of facial nerve function. 
Liu & Fagan (2001) in their review noted 
that the best result can be obtained with 
cable grafting is House-Brackmann 
grade III. Preservation of facial nerve is 
possible in some cases by stripping sur-
gery, that is, microdissection at the junc-
tion of the nerve and tumour capsule or 
surgical decompression of the tumour 
especially at the cerebellopontine angle. 
This approach is advocated in those with 
good pre-operative facial nerve function 
(Kim et al. 2009). 
The principles of surgical approach de-
pend mainly on the tumour origin, tumour 
extension and hearing function. Intra-
temporal FNS are approached via the 
mastoid with hearing preservation. Tu-
mours involving the labyrinthine segment 
are removed via middle cranial fossa ap-
proach with hearing preservation or 
translabyrinthine approach in those with 
non-serviceable hearing. In large tu-
mours involving the cerebellopontine an-
gle the posterior cranial fossa approach 
is a viable option. 
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CONCLUSION 
 
The presenting symptoms of FNS are 
commonly hearing loss and progressive 
facial nerve palsy which are non specific. 
Pre-operative diagnosis still remains a 
diagnostic dilemma especially when the 
facial nerve function is normal. Patients 
should always be counselled regarding 
facial nerve paralysis before any ear sur-
gery because the diagnosis of FNS is 
often made intra-operatively. The integr-
ity of the facial nerve should be pre-
served whenever possible. If part of the 
nerve is sacrificed, end to end anatomo-
sis or cable grafting gives the best out-
come for facial nerve function. 
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